Innovating Works
RV001: RV001 An anti metastatic cancer vaccine RHOVAC APS tramitó un H2020: H2020-EIC-SMEInst-2018-2020 Prostate cancer is the most commonly diagnosed cancer in men, with 1.7M new cases and 0.5M deaths anticipated by 2030 worldwide. Although me...
2019-09-27 - 2022-09-30 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.